Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $25.39 in the prior trading day, Sionna Therapeutics Inc (NASDAQ: SION) closed at $24.55, down -3.31%. In other words, the price has decreased by -$3.31 from its previous closing price. On the day, 0.55 million shares were traded. SION stock price reached its highest trading level at $26.48 during the session, while it also had its lowest trading level at $24.295.
Ratios:
Our goal is to gain a better understanding of SION by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.33 and its Current Ratio is at 35.33. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on Sep-04-25, initiated with a Sector Perform rating and assigned the stock a target price of $22.
On September 04, 2025, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 02 ’25 when Ridloff Elena sold 8,836 shares for $25.08 per share. The transaction valued at 221,607 led to the insider holds 38,532 shares of the business.
Ridloff Elena sold 748 shares of SION for $18,835 on Aug 29 ’25. The CFO & Head of Corp. Dev. now owns 47,368 shares after completing the transaction at $25.18 per share. On Aug 26 ’25, another insider, Cloonan Michael, who serves as the President & CEO of the company, sold 17,574 shares for $24.96 each. As a result, the insider received 438,647 and left with 547,343 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SION now has a Market Capitalization of 1083632000 and an Enterprise Value of 830298624.
Stock Price History:
Over the past 52 weeks, SION has reached a high of $26.50, while it has fallen to a 52-week low of $7.26. The 50-Day Moving Average of the stock is 22.89%, while the 200-Day Moving Average is calculated to be 51.29%.
Shares Statistics:
The stock has traded on average 197.89K shares per day over the past 3-months and 230680 shares per day over the last 10 days, according to various share statistics. A total of 44.13M shares are outstanding, with a floating share count of 23.38M. Insiders hold about 47.03% of the company’s shares, while institutions hold 57.87% stake in the company. Shares short for SION as of 1755216000 were 3600368 with a Short Ratio of 18.19, compared to 1752537600 on 3530059. Therefore, it implies a Short% of Shares Outstanding of 3600368 and a Short% of Float of 13.71.
Earnings Estimates
Investors are keenly observing as 6 analysts analyze and rate the current performance of Sionna Therapeutics Inc (SION) in the stock market.The consensus estimate for the next quarter is -$0.55, with high estimates of -$0.43 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$1.81 and -$2.32 for the fiscal current year, implying an average EPS of -$2.04. EPS for the following year is -$2.07, with 6.0 analysts recommending between -$1.59 and -$2.4.
